Hydroxy Dabrafenib | CAS 1195767-77-1 - Request Quote
Hydroxy Dabrafenib
| SZ CAT No: | SZ-D120012 |
| CAS No | 1195767-77-1 |
| Mol.F. | C23H20F3N5O3S2 |
| Mol.Wt. | 535.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Hydroxy Dabrafenib is chemically N-(3-(5-(2-Aminopyrimidin-4-yl)-2-(1-hydroxy-2-methylpropan-2-yl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide. Hydroxy Dabrafenib is supplied with detailed characterization data compliant with regulatory guideline. Hydroxy Dabrafenib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabrafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1195767-77-1
Purchase 1195767-77-1
Order 1195767-77-1
Enquire 1195767-77-1
price of 1195767-77-1
1195767-77-1 Supplier
1195767-77-1 Manufacturer
1195767-77-1 Exporter
buy high quality Hydroxy Dabrafenib
Purchase Hydroxy Dabrafenib
Hydroxy Dabrafenib suppliers
Hydroxy Dabrafenib manufacturers
Hydroxy Dabrafenib price
Order Hydroxy Dabrafenib
Enquire Hydroxy Dabrafenib
Hydroxy Dabrafenib cost
Hydroxy Dabrafenib Supplier
Hydroxy Dabrafenib Distributor
Hydroxy Dabrafenib for Method Validation
Dabrafenib Reference Standard
Hydroxy Dabrafenib for ANDA Filing
Hydroxy Dabrafenib for Forced Degradation Studies
Hydroxy Dabrafenib Identification Standards
Hydroxy Dabrafenib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


